104777-32-4 Usage
General Description
Ethanone, 2-bromo-1-(3-methyl-5-isoxazolyl) is a chemical compound with the molecular formula C8H8BrNO2. It is also known by the name 2-Bromo-1-(3-methyl-5-isoxazolyl)ethanone. Ethanone, 2-bromo-1-(3-methyl-5-isoxazolyl) is a brominated isoxazole derivative that is commonly used in the synthesis of pharmaceutical and agrochemical products. It is also used as an intermediate in organic synthesis. The chemical structure of ethanone, 2-bromo-1-(3-methyl-5-isoxazolyl) contains a bromine atom attached to a carbon atom, along with an isoxazole ring and a ketone functional group. Ethanone, 2-bromo-1-(3-methyl-5-isoxazolyl) is of interest to researchers and chemists for its potential applications in various fields, including medicine and agriculture.
Check Digit Verification of cas no
The CAS Registry Mumber 104777-32-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,0,4,7,7 and 7 respectively; the second part has 2 digits, 3 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 104777-32:
(8*1)+(7*0)+(6*4)+(5*7)+(4*7)+(3*7)+(2*3)+(1*2)=124
124 % 10 = 4
So 104777-32-4 is a valid CAS Registry Number.
InChI:InChI=1/C6H6BrNO2/c1-4-2-6(10-8-4)5(9)3-7/h2H,3H2,1H3
104777-32-4Relevant articles and documents
Synthesis and pharmacological characterization of new analogs of broxaterol
De Amici,Conti,Dallanoce,Kassi,Castellano,Stefancich,De Micheli
, p. 69 - 80 (2007/10/03)
A series of isoxazole derivatives structurally related to broxaterol 1 has been prepared and tested for their potency to β1 and β2 adrenergic receptors. At variance with broxaterol, none of the tested compounds displayed agonistic activity. The 3-isopropenyl derivative 5f is the most potent antagonist both in the trachea and atria preparations.
N-(4-isoxazolylthiazol-2-yl)oxamic acid derivatives as potent orally active antianaphylactic agents
Chiarino,Grancini,Frigeni,Biasini,Carenzi
, p. 600 - 605 (2007/10/02)
A series of N-(4-isoxazolylthiazol-2-yl)oxamic acid derivatives was synthesized and tested on the passive cutaneous anaphylaxis (PCA) model in rats to verify its potential antianaphylactic activity. These compounds were prepared by reaction of an appropri
